Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$819,210
+$191,008 QoQ
Shares Held
683
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#3,320
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Powell Investment Advisors, LLC holds $3,323,936 across 5 Drug Manufacturers - General names. LLY ranks #2 (24.6% of the industry book) .
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $819,210 | 683 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $628,202 | 683 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $734,006 | 683 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $521,129 | 683 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $532,418 | 683 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $564,096 | 683 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $527,276 | 683 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $605,097 | 683 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $600,266 | 663 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $497,116 | 639 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $372,485 | 639 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $332,483 | 619 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $290,298 | 619 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $212,576 | 619 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $226,454 | 619 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $278,081 | 860 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $278,837 | 860 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $246,278 | 860 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $234,234 | 848 | Shares | Sole | 2022-01-14 | |
| No filing history on record for this holder in this stock. | ||||||